According to a report by Proactiveinvestors, British e-cigarette brand Chill Brands is planning to sell its nicotine-free e-cigarette product "Chill Zero" in prominent UK chain store WH Smith as well as airports.
This will prompt Chill Zero to introduce its nicotine-free e-cigarette product into its 150 travel retail stores, reaching thousands of daily travelers. Their target audience includes individuals aged 18 to 35, and even a broader age group, with the aim of offering an alternative to nicotine products.
As many individuals aspire to gradually reduce their nicotine intake, the company aims to assist them in gradually transitioning away from traditional tobacco and nicotine products. They also offer nicotine-free alternatives for those who enjoy social smoking without creating a chemical dependency.
Recent news releases have caused a market reaction, with a slight increase in the stock price of Chill Brands. However, the increase is not significant. Additionally, investors may be waiting to see concrete evidence of the company's retail channel expansion and growth.
Chill Brands states that, despite public concerns surrounding e-cigarettes in recent times, it is worth noting that the industry has already prepared to adapt to regulatory changes. They have also taken steps, such as partnering with Phoenix company for responsible waste management and compliance, to ensure they maintain a legal status in the market.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
